Type 2 Diabetes (T2D), a major public health issue reaching worldwide epidemic, has been correlated with lower olfactory abilities in humans. As olfaction represents a major component of feeding behavior, its alteration may have drastic consequences on feeding behaviors that may in turn aggravates T2D. In order to decipher the impact of T2D on the olfactory epithelium, we fed mice with a high fructose diet (HFruD) inducing early diabetic state in 4 to 8 weeks. After only 4 weeks of this diet, mice exhibited a dramatic decrease in olfactory behavioral capacities. Consistently, this decline in olfactory behavior was correlated to decreased electrophysiological responses of olfactory neurons recorded as a population and individually. Our results demonstrate that, in rodents, olfaction is modified by HFruD-induced diabetes. Functional, anatomical and behavioral changes occurred in the olfactory system at a very early stage of the disease.
Olfactory sensory neurons (OSNs) represent the first element of the olfactory system. They convert the chemical information of odorants into electrical information integrated by the brain. Several factors can modulate peripheral olfactory neurons among which the environment and metabolic state.
Several receptors of the metabolic peptides and hormones involved in the nutritional status are largely expressed in the olfactory epithelium1,2,3,4,5,6. These receptors and hormones will take part in the modulation of odor detection by the nutritional status. Among these actors, insulin and leptin vary with both nutritional state and diet. They modulate the olfactory system and olfactory-driven behaviors4,5,7,8,9. So far, there is little data on the effect of diet at the peripheral level of the olfactory system. An hyperlipidemic diet generating metabolic syndrome induces anatomical, functional changes in the olfactory mucosa as well as behavioral alterations10. Besides this study, the influence of metabolic disorders on olfaction has been rarely explored. Among them, diabetes, especially type 2 diabetes (T2D), represents a major public health issue since it reaches worldwide epidemic level11,12. In humans, T2D is associated with poorer olfactory performance at the level of identification, discrimination or detection threshold13,14,15. In most experiments, the state of T2D and the potential role of secondary pathologies (such as diabetic neuropathy) are rarely mentioned. The effect of diabetes in itself and especially early diabetes on olfaction is unknown.
Overconsumption of fructose is now considered a major contributor to T2D development16 and HFruD is largely used to induce T2D in rodents17,18. Thus, in this study, we expose mice to a fructose enriched diet (HFruD for High Fructose Diet) inducing diabetes after 4 to 8 weeks. We then observe the consequences of this diet on the peripheral olfactory system as well as on olfactory behaviors. We find that overconsumption of fructose rapidly induces structural and functional changes in the peripheral olfactory system. Amplitudes of electro-olfactogram responses to odorants are reduced while their kinetics are modulated. Cell dynamics are impaired with a reduced apoptosis level and an increased density of mature neurons. Using patch-clamp recordings on individual olfactory sensory neurons, we show that HFruD decreases OSNs’ responses to odorant stimulation associated with reduced excitability and transduction pathway capacity. Finally HFruD strongly disrupts olfactory behaviors: diabetic mice are unable to discriminate between 2 odorants and are slower to find food in a test based on olfactory cues. Our results show that early diabetic state induced by HFruD dramatically disrupts olfaction.
HFruD elicits functional impairment of olfactory epithelium
First we confirmed that the High Fructose Diet (HFruD) used here can induce type 2 diabetes. Mice were fed with HFruD for 4 or 8 weeks. As expected, the HFruD progressively induced diabetes phenotype with fasting hyperglycemia, hyperinsulinemia and glucose intolerance (Supplementary Fig. 1). These effects appeared as early as after 4 weeks of diet and persisted after 8 weeks of diet.
To assess the physiological consequences of HFruD on the peripheral olfactory system, electrical activity of olfactory epithelium in response to odorant stimulations was measured using air-phased electro-olfactogram (EOG) as described earlier19,20. Responses to octanol and acetophenone were recorded after 4 (Supplementary Fig. 2) and 8 (Fig. 1) weeks of diet. Amplitudes of EOG responses were measured for concentrations of odorants ranging from 1:10000 to 1:10 vol/vol dilution. EOG kinetics were measured on the responses to stimulations with the 1:1000 concentration of odorants.
After 4 weeks of diet, EOG amplitudes in response to octanol decreased in HFruD animals (p = 0.06, Supplementary Fig. 2a2) only for the highest concentration. No difference in EOG kinetics was observed for octanol responses (Supplementary Fig. 2a3–6). In response to acetophenone, EOG amplitudes were decreased in HFruD animals (p < 0.01, Supplementary Fig. 2b2) for all concentrations except 1:10,000. The responses to acetophenone were slower since (i) the rise time increased by a factor 1.27 (p < 0.01, Supplementary Fig. 2b4) and (ii) both fast and slow decay times increased by a factor of 1.37 (p < 0.001, Supplementary Fig. 2b5) and of 1.57 (p < 0.01, Supplementary Fig. 2b6) respectively.
After 8 weeks of HFruD, the reduction of EOG amplitudes was amplified and generalized to the 2 odorants tested: EOG were strongly reduced for both octanol (p < 0.001, Fig. 1a2) and acetophenone (p < 0.001, Fig. 1b2) at all concentrations. All parameters of the responses’ kinetics were also modified by HFruD: the responses were smaller and slower. The area under the curves was reduced for stimulations by both octanol (by 15%, p < 0.05, Fig. 1a3) and acetophenone (23%, p < 0.05, Fig. 1b3). Furthermore, rise time, slow and fast decay times were higher for HFruD animals after stimulation by octanol (by factors of, respectively: 1.58, p < 0.001; 1.28, p < 0.05; 1.78, p < 0.05; Fig. 1a4). For acetophenone stimulation, rise time and fast decay time increased in HFruD mice compared to control mice (by factors of, respectively: 1.49, p < 0.01; 1.25, p < 0.05; Fig. 1b4).
To summarize, after 8 weeks of diet, EOG amplitudes were reduced and EOG kinetics were slower in HFruD animals compared to control animals. After 4 weeks of HFruD, EOG responses show intermediate changes: they were slower in HFruD animals compared to control only for responses to acetophenone. These results could be explained by changes in the cell dynamics in the olfactory mucosa and/or functional impairment at the level of individual neurons.
HFruD alters cell dynamics in the olfactory mucosa (OM)
Cell dynamics in the olfactory epithelium is characterized by a constant regeneration of OSNs from proliferating basal cells and a subtle control of the apoptosis/proliferation balance21. Here apoptosis level in the olfactory mucosa was assessed by immunohistochemistry using an antibody against cleaved caspase 3 (Fig. 2a). After 4 weeks of diet, no difference in the cleaved caspase 3 labeled area was observed between control and HFruD animals. However, after 8 weeks of diet, HFruD animals displayed a 48.1% decrease in cleaved caspase 3 signal in the olfactory mucosa compared to control animals (p < 0.001, Fig. 2a3). A cell counting quantification procedure confirmed these results: 8 weeks of HFruD induces a 49.0% reduction of the number of caspase 3 labeled cells compared to control animals (p = 0.00146, see Supplementary Fig. 3a). In order to further confirm these results, we measured apoptosis using DeadEndTM Fluorometric TUNEL system after 8 weeks of HFruD. Using this technique, a 53% decrease in apoptosis was also measured in HFruD animals compared to control animals (p < 0.05, Supplementary Fig. 3b). Proliferation of basal cells was assessed by immunohistochemistry using an antibody against PCNA (for Proliferating Cell Nuclear Antigen), a classical proliferating cell marker22. No difference between control and HFruD animals was found either after 4 or 8 weeks of diet (Fig. 2b).
What are the consequences of this disruption of cell turnover in the OM? The number of mature OSNs was measured by immunohistochemistry using an antibody against OMP (Fig. 3a). To quantify the number of mature neurons, we measured relative areas of OMP-labelling (see methods). No difference in relative OMP area was found after 4 weeks of diet between control and HFruD animals. However, after 8 weeks of diet, HFruD animals displayed a 20% increase in OMP-labelling area (p < 0.05, Fig. 3a3). Meanwhile the thickness of the olfactory mucosa did not vary between control and HFruD mice whether at 4 weeks or at 8 weeks of diet (Supplementary Fig. 3c), We also measured the density of MOR23 expressing neurons using a flat mount preparation of septal olfactory epithelium after 8 weeks of HFruD. For the MOR23 population of OSNs, a 17.59% increase of OSNs’ density was measured in HFruD animals compared to control animals (p < 0.05, Fig. 3b). These results are consistent with the increase in OMP staining in HFruD animals compared to control animals. Reconstructions of cilia on MOR23 neurons revealed no difference in the number and the length of their cilia (Supplementary Fig. 3d). These data show that HFruD elicits an increase in the number of neurons, especially mature neurons in the OM.
HFruD reduces the sensitivity and modulates the kinetics of the odorants’ responses in individual OSNs
In order to monitor the effect of HFruD on the odorant elicited responses in individual OSNs, we performed patch-clamp recordings on MOR23 expressing neurons after 8 weeks of diet. These recordings were performed on the dendritic knob of GFP labeled neurons in an intact preparation as described previously19,23. In voltage clamp mode, all MOR23 neurons respond to increasing Lyral concentration stimuli with inward currents showing increasing maximum amplitude. These responses were observed in both control (Fig. 4a1) and HFruD (Fig. 4a2) mice. The peak transduction currents versus the concentration are plotted and fitted with the Hill equation: I = Imax/(1+(K1/2/C)n), where I represents the peak current, Imax the maximum response at saturating concentrations, K1/2 the concentration at which half of the maximum response was reached, C the concentration of odorant and n the Hill coefficient (Fig. 4b). HFruD induced changes in the dose-response characteristics of MOR23 neurons. First, the responses were smaller since the average maximum amplitude elicited by saturating concentrations was reduced by 35% in HFruD mice compared to control mice (p < 0.05, Fig. 4c1). Second, the HFruD neurons were less sensitive to Lyral since the dose-responses were shifted to the right: the K1/2 increased from 3.0 μM ± 1 in control cells to 15.6 μM ± 5 (p < 0.05, Fig. 4c2) in HFruD cells. Besides, the population of HFruD neurons exhibits a much larger variability than control neurons: a one tail F-test shows that the variance of the HFruD group is significantly larger than the variance of the control group (F = 0.047, p = 0.000017). However, there was no effect of HFruD on the dynamic range of the responses since the Hill coefficient in HFruD or control mice did not differ significantly (Fig. 4c3). These results indicate that HFruD induces a reduction of sensitivity and of maximum responses of MOR23 expressing OSNs.
We also noticed that the shape of the responses differed in HFruD cells compared to control cells. In fact, inward currents in HFruD neurons were characterized by a smaller amplitude and a slower return to the baseline compared to control neurons. We therefore analyzed the kinetics of the responses for a specific concentration of Lyral, 10−5 M, close to the K1/2. All MOR23 neurons tested responded at this concentration. The kinetics parameters changed between HFruD and control mice. First, the maximum amplitude dropped by 34% between control and HFruD neurons (p < 0.05, Fig. 4d1). Second, the responses’ lengths were shorter since the time at 50% decreased by 45% in HFruD mice compared to control mice (p < 0.05, Fig. 4d4). Third, the total current elicited was also 57% smaller in HFruD mice compared to the total current in control mice (p < 0.05, Fig. 4d3), further indicating that the responses were shorter. Meanwhile the responses’ onset was not faster since the rise time did not change significantly (Fig. 4d2).
To further monitor the total capacity of their transduction pathway, we stimulated MOR23 OSNs with a mixture of 200 μM IBMX and 20 μM of forskolin. The maximum amplitude of the inward current elicited by IBMX + forskolin mixture was 46% smaller in HFruD mice (108.0 pA ± 26.8; n = 9) compared to control mice (199.8 pA ± 32.2; n = 11, p < 0.05). This result indicates that HFruD induces a reduction in the transduction machinery’s capacity in MOR23 neurons.
Does HFruD also affect other membrane properties of MOR23 neurons such as firing properties and excitability? We first recorded their spontaneous firing activity in the current clamp configuration during 30 to 40 s epochs. There was no difference between control and HFruD neurons neither for the average firing frequency, nor for the instantaneous firing frequency (Supplementary Fig. 4a). Then the excitability of the neurons was measured by the injection of a 7 pA depolarizing current over 2 s epochs. The 7 pA current induced action potentials in both groups but HFruD neurons exhibited a lower excitability (Supplementary Fig. 4b): (i) the depolarizing current induced 53% less action potentials in HFruD neurons compared to control neurons (p < 0.05); (ii) the latency (time between the onset of the stimulating current and the first spike) increased by a factor 1.42 in HFruD neurons compared to control neurons (p < 0.01). Meanwhile, the interspike interval did not change (p = 0.33). The reduced excitability of HFruD neurons was not due to changes in the resting membrane potential since we did not observe differences for this parameter between control (−64.5 mV ± 2, n = 8) and HFruD neurons (−65.9 mV ± 2, Z = 0.48, p = 0.91, KS-test).
These results show that, after 8 weeks of diet, HFruD induced in MOR23 neurons a reduction of the response to the ligand of the MOR23 receptor. This reduction may be due to a lower transduction pathway capacity associated with a lower excitability.
HFruD induces impairment of olfactory abilities
Olfactory abilities were measured in animals using several behavioral experiments. First, the ability of animals to differentiate between two unfamiliar odorants was assessed using the habituation/dishabituation test. Animals were tested longitudinally: before any change in their diet (Fig. 5a) and then after 4 (Fig. 5b) and 8 weeks of HFruD (Fig. 5c). The ability to differentiate between two odorants is characterized by a normal habituation and dishabituation24. In our experimental set-up, we exposed four times the animals to octanol then to acetophenone. We observed a similar habituation and a similar dishabituation in both groups before the change of diet (Fig. 5a, p = 0.86 with two way ANOVA).
After 4 weeks of diet, HFruD animals displayed altered sniffing time compared to control animals (p < 0.01 with two way ANOVA). Both control and HFruD animals displayed normal habituation. However only control animals displayed increased sniffing time for dishabituation (Fig. 5a): the sniffing time between the last octanol trial and the acetophenone trial increased in control animals (p < 0.001) while remained constant in HFruD animals (p = 0.93). After 8 weeks of diet, both control and HFruD animals still displayed habituation. Again only control animals displayed increased sniffing time for dishabituation (p < 0.001) while HFruD animals did not show dishabituation (p = 0.6). Statistical significance values are summarized on the Supplementary Table S1A.
To monitor longitudinally our two groups of animals, two ratios were calculated: a habituation ratio (last trial with octanol on first trial with octanol, Fig. 5d) and a dishabituation ratio (trial with acetophenone on last trial with octanol, Fig. 5e). Habituation was not modified by HFruD (p = 0.27 with two way ANOVA) but dishabituation was clearly reduced for HFruD animals compared to control animals (p < 0.05 with two way ANOVA): only HFruD animals displayed a decreased dishabituation ratio between 0 and 4 or 8 weeks of diet. Furthermore, dishabituation ratio of HFruD animals was 62% smaller than that of control animals after 4 weeks of diet (p < 0.01) and 70% smaller after 8 weeks of diet (p < 0.001, Fig. 5e).
To make sure that these results were due to an inability to differentiate octanol and acetophenone and not just to a decrease in detection of acetophenone in HFruD animals, the same test was performed on a different group of animals reversing the order of presentation of the two odorants: here acetophenone was used as the habituation odorant and octanol as the dishabituation odorant. The same pattern of results was found by doing the test this way, i.e. an impairment of HFruD animals to perform the habituation/dishabituation test (Supplementary Fig. 5 and Supplementary Table S1B). These results indicate that HFruD clearly reduces the olfactory discrimination in mice. This reduction takes place already after 4 weeks of diet and is maintained after 8 weeks.
General olfactory abilities for a food odor were assessed using the buried food test, in which we measured the time needed to retrieve a food or control item buried under the bedding (Fig. 6). Animals were tested before and after 4 to 8 weeks of diet to do longitudinal follow up of each animal. Decreased olfactory abilities were found in HFruD animals compared to control animals (p < 0.001 with two way ANOVA, Fig. 6). More precisely the time needed to retrieve the food item did not change for control animals throughout time, i.e. between 0 and 4 or 8 weeks of diet. By contrast HFruD animals displayed an 2.7 fold increase in the time needed to retrieve a food item between 0 and 4 weeks (p < 0.01) and a 5 fold increase between 0 and 8 weeks of diet (p < 0.001). The time to retrieve the food item is therefore 2 to 3 times higher in HFruD mice compared to control mice after 4 to 8 weeks. In the meantime, the time to retrieve a control item was not modified by the HFruD (p = 0.82 with two way ANOVA). In summary, HFruD rapidly induces a strong reduction of the ability to detect and find a food item.
Several non-olfactory factors can also explain those behavioral results. To test whether HfruD animals were simply less motivated to forage for food, the same experiment was performed but this time with a visible food item simply placed on the bedding. After 8 weeks of HFruD the time needed to retrieve the food item was not different between control and HFruD animals (p = 0.64, Supplementary Fig. 6b).
The two behavioral tests are also dependent on locomotor activity and anxiety of animals. To test whether these parameters are affected by HFruD, open field experiments were performed before and after 4 to 8 weeks of diet (Supplementary Fig. 6a). No effect of HFruD was found on locomotor activity measured by total walking distance and average speed (respectively p = 0.52 and p = 0.47 with two way ANOVA). No effect of HFruD was found on anxiety assessed using thigmotaxis, a natural behavior of mice which avoid the center of an open arena (p = 0.54 with two way ANOVA).
In summary, our results show that olfactory behaviors are rapidly and profoundly disrupted in mice under HFruD.
Here we report that a High Fructose Diet rapidly induces early diabetic state in mice and modifies the peripheral olfactory system. First, HFruD induces changes in the cell dynamics in the olfactory epithelium. Second, HFruD disrupts the peripheral responses to odorants: we observe reduced amplitude and kinetics of the EOG associated with reduced sensitivity and transduction pathway capabilities in individual OSNs. HFruD, inducing early diabetes, strongly disrupts olfaction: animals are not able to discriminate between 2 odorants and need more time to retrieve a food item in a test based on olfactory cues.
We observe an increase of the number of mature OSN (Fig. 3). Meanwhile, the amplitude of the EOG responses to odorants decreases (Fig. 1). This result seems counterintuitive as while neurons mature from P0 to P30, their sensitivity increases25. However, we also observe that individual OSNs exhibit a reduced sensitivity and transduction pathway capacity (Fig. 4) and this result is consistent with the decreased response recorded in EOG. One hypothesis might be that the mature neurons observed in HFruD mice are in fact aging neurons with reduced transduction properties. The population of recorded OSNs shows a large variability in their sensitivity supporting this hypothesis: the OSN population is more diverse with newborn and mature neurons as well as more aging neurons.
In HFruD animals, the apoptosis level in the OM is lower compared to control animals (Fig. 2). This lower level of apoptosis in HFruD mice compared to control of the same cohort is consistent with a higher number of MOR23 OSNs (Fig. 3). This lower level of apoptosis is also consistent with the increased OMP stained OM area in HFruD mice. Indeed, even if its quantification can be biased due to its important expression, this marker is expressed by mature neurons26,27 and it should be more present if apoptosis level is decreased. While the number of mature neurons increases, the thickness of the olfactory epithelium did not change (Supplementary Fig. 3). These results suggest that the number of other cell types, whether immature neurons or supporting cells, might decrease under HFruD. Further investigations will provide more information about these cell types and the mechanism involved in changing the balance between mature neurons and other cell types during cell proliferation. One hypothesis to explain the change in the apoptosis level induced by HfruD is based on the action of insulin in the OM. Indeed, after 4 to 8 weeks of HFruD, animals present a phenotype of early diabetic state with hyperinsulinemia and hyperglycemia (Supplementary Fig. 1). At this stage, pancreatic beta cells generate a large amount of insulin inducing fasting hyperinsulinemia (compensation period of diabetes28). Since insulin is known to be an anti-apoptotic factor for olfactory epithelium cells in vivo29, the hyperinsulinemia may in turn induce a reduction of apoptosis in the OM. As diabetes advances, the level of insulin drops30. It could be of interest to follow the consequences of advanced diabetes on the OM’s dynamics. In our conditions, diabetes alone is sufficient to rapidly disrupt cell dynamics, but long term consequences of diet induced diabetes on cell dynamics may probably be even more dramatic. These long term effects may however be due to secondary complications that appear later in the disease31. Another model of long term application (6 months) of Western diet induces obesity10. This long term metabolic disorder paradigm induces a reduction of the number of mature neurons with increased apoptosis and proliferation. However no hyperglycemia or hyperinsulinemia was observed in these conditions suggesting that this increase in apoptosis would be due to obesity. Our data show that early diabetic phenotype is sufficient to induce anatomical changes in the olfactory system.
Could hyperglycemia induce cell dynamic changes? Hyperglycemia induces apoptotic changes in dorsal root ganglion (DRG) neurons and Schwann cells both in vivo and in vitro32,33,34. It seems therefore doubtful that, in our model, hyperglycemia would reduce apoptosis. Modulation of cell dynamics could potentially involve Neuropeptide Y (NPY) since NPY may be involved in the regulation of apoptosis and microvillar cells in the epithelium35. However NPY levels in HFruD mice are unknown. Finally, at this stage of diabetes, we can exclude diabetic neuropathy since neuropathy primarily starts on large cells and appears late in the development of diabetes in humans31. In rodents, 16 weeks of HFruD is not long enough to develop diabetic neuropathy36. Hyperinsulinemia remains the main hypothesis for HFruD effects on the cell dynamics in the OM.
HFruD rapidly induces a reduction of the sensitivity of the olfactory epithelium observed through EOGs (Fig. 1 and Supplementary Fig. 2). Both amplitude and kinetics are modulated by HFruD, indicating that the transduction pathways of OSNs are modulated in our conditions. Interestingly, long term High Fat diet induces reduction in amplitude of EOGs without changes in the EOG kinetics10 associated with a reduction of mature neurons. The effects of short term diabetes and long term metabolic disorder might therefore involve different pathways. We also report that diabetes induced by 8 weeks of HFruD modulates functional properties of individual OSNs: the odorant responses’ amplitude and also the sensitivity of OSNs are reduced (Fig. 4). This lower sensitivity to odorant stimulus is associated with a reduction of both the excitability (Supplementary Fig. 4) and the total transduction pathway capacities of OSNs. Such functional changes could be triggered by modifications of the cilia’s structure37. In our conditions however, no modification of length or number of OSNs’ cilia was observed (Supplementary Fig. 3b) suggesting other mechanisms such as a modulation of transduction pathway proteins’ transcription levels. Both chronic hyperglycemia and hyperinsulinemia may explain the modulation of OSNs’ activity. However, to our knowledge, there is no report of OSNs glucose sensing properties that might modulate their activity. On the other hand, rats EOGs and OSNs’ activity can be modulated by insulin2,8. However, these results show that acute application of insulin reduces EOG amplitude and increases the spontaneous activity and excitability of OSNs. Here we possibly observe the effects of chronic hyperinsulinemia leading to insulin resistance. Chronic hyperinsulinemia may have consequences on the OSNs properties through the insulin transduction pathway. Both MAPK and PI3K-Akt pathways could be activated by insulin and lead to gene regulation of transduction pathway proteins (for review, see refs 38 and 39). Finally, hyperinsulinemia and hyperglycemia are known to modulate mitochondria’s properties40,41. Since mitochondria are fundamental for shaping the OSNs’ responses42, the impact of chronic hyperglycemia and hyperinsulinemia on OSNs’ mitochondria will need to be investigated further: i.e. the expression of mitochondrial proteins, mitochondrial trafficking or ATP production.
HFruD profoundly disrupts olfactory behaviors, whether during a discrimination task (Fig. 5) or during olfactory based food searching task (Fig. 6). These behavioral effects could be explained by anxiety disorders. It was recently shown that HFruD does not induce depressive disorders in mice and has no effect on anxiety-related behaviors43. Our data also confirmed that anxiety is not changed in HFruD animals (Supplementary Fig. 6). Consequently, anxiety and/or depression related disorders cannot explain our observations. Consequently, our data show an effect of HFruD on olfactory capacities. Our observation of functional impairment at the periphery fits well with the behavioral data. However, behavioral alterations will definitely also be due to changes at more central levels. For instance, the olfactory bulb will be modulated by HFruD since it is extremely sensitive to insulinemia and glycemia44,45. The entire OB network and more specifically mitral cells should be modulated46. Here too, the role of chronic hyperinsulinemia could in part explain our behavioral results. Indeed, insulin icv injection in the lateral ventricle decreases olfactory-driven behaviors for both food and non-food odors9.
Are HFruD mice hungrier than control mice? Hunger is often associated with type 2 diabetes in Humans. However, this is not always the case when using a HFruD in mice: for instance, food intake is not modified by the HFruD47,48. The visible cheese experiment presented here (Supplementary Fig. 6) takes place with lights on: mice can therefore easily locate the food source using visual and olfactory cues. Consequently, the latency to grab the food is more related to motivation of the animal to eat. There is no difference between HFruD and control mice for retrieving the visible food item. This data fits well with the absence of difference in food intake47,48 to show that HFruD mice are not hungrier. Results presented here are therefore the consequence of olfactory dysfunction.
Our data reinforce observations in diabetic patients showing a reduction of olfactory capacities13,14,15. In human subjects however, it remains difficult to separate the primary role of diabetes and the role of secondary complications such as neuropathy. Some studies even proposed that olfactory dysfunctions in diabetic patients are due to, or at least aggravated by, secondary pathologies13,14,15. In our experimental paradigm, animals exhibit an early diabetic phenotype. This phenotype is therefore sufficient to disrupt olfactory behavior and physiology. Therefore, it would be possible that olfactory dysfunctions during the onset of T2D and after the appearance of secondary pathologies rely on different mechanisms. Since olfaction plays a major role in regulating food intake, its early modulation could aggravate diabetic phenotypes through deregulation of feeding behaviors that may in turn intensify the T2D symptoms.
For detailed Methods, see Supplementary Information
Animals and diets
Gene-targeted MOR23-IRES-tauGFP male mice were used in all experiments. From weaning to 5 weeks old, mice were maintained in a control diet (A04, sugar: corn starch 59.9%, Safe). Once they reach the postnatal age of 5 weeks, mice were split in two groups: one group remained fed with the control diet and the second one with an enriched fructose diet (HFruD, sugar: fructose 60%, Safe) for 4 to 8 weeks. All experiments were carried out in accordance with the guidelines of the European Community for the use and care of live animals and resulting French regulations. Accordingly, all experimental protocols were approved by the French Ministry of Higher Education and Research (reference 01286.02).
Glucose tolerance test and insulin assay
Intolerance to glucose was assessed using intraperitoneal glucose tolerance test (ipGTT). Glucose was injected intraperitoneally (2 g/kg body weight) 5 h after food was removed. Blood glucose was then determined with an Accu-Chek Performa glucometer (Roche) from blood sample collected from the tail vein, before and 15, 30, 45, 60, 90 and 120 minutes after glucose injection. Blood samples were also collected just before glucose injection to perform quantitative analysis of insulin level. Insulin serum levels were determined using an alphaLISA Human insulin immunoassay kit (Perkin Elmer). For ipGTT, a two way ANOVA was performed followed by Fisher’s LSD post-hoc test. Areas under curve were analyzed using a Student’s t test and glycemia and insulinemia using a Mann-Whitney’s test. All statistics were performed using Statistica software.
Flat mount preparation
Septal olfactory epithelia were dissected in a Ringer solution. One part of them was mounted in a perfused chamber and visualized using an Olympus BX51WI microscope (40X objective) coupled to a PCO Imaging SensiCam camera. An extra 2x magnification was achieved by a magnifying lens in the light path. Images were analyzed with FIJI and OSNs’ cilia were reconstructed using the FIJI plugin Simple Neurite Tracer. Differences in number and length of cilia were analyzed using a Mann-Whitney’s test with Statistica software. The other part of septal epithelia was then processed and neurons observed in a flatmount epithelium as published earlier19. The neuronal density was calculated as the ratio of the number of GFP-containing neurons against surface identified as the area including all visible GFP containing neurons. Differences in the neuronal density were analyzed using a Mann-Whitney’s test with Statistica software.
Olfactory epithelium’s sections
Olfactory epithelium sections were obtained as published earlier20. For staining, sections were incubated either with a mouse anti-PCNA antibody (1/100, GeneTex), a rabbit anti-cleaved caspase 3 antibody (1/400, Ozyme) or a goat anti-OMP antibody (1/500, Wako). Sections were then incubated with, respectively, a goat anti-mouse Alexa Fluor 488 antibody (1/1000, molecular probes), a goat anti-rabbit Alexa Fluor 488 antibody (1/1000, molecular probes) or a donkey anti-goat Alexa Fluor 555 antibody (1/1000, molecular probes). Alexa Fluor 488 (green) was used since, in our experimental conditions, at the end of the fixation and decalcifications steps, olfactory epithelia did not exhibit any remaining intrinsic GFP fluorescence (Supplementary Fig. 7a). Cell nuclei were labelled using Hoechst staining (1/5000, molecular probes). TUNEL staining was performed in accordance with the manufacturer’s instructions (DeadEndTM Fluorometric TUNEL system, Promega) and a final Hoechst staining was performed. For cleaved caspase 3, PCNA and TUNEL staining, results were expressed in relative expression of fluorescent staining compared to total olfactory epithelium area as performed earlier29,49,50. Apoptosis and proliferation were quantified by the area of signal rather than the number of cells49,50 to overrule the difficulty of counting very fragmented cells for caspase 3 staining and overlapping stained cells for PCNA. The apical area of the epithelium, which contains only cilia and no cell body, was excluded from the region of interest for quantification because of its particularly strong autofluorescence (Supplementary Fig. 7b). PCNA, TUNEL and C3C results were expressed as a relative value of the control group. To further validate the relevance of the fluorescence quantification, C3C labeling was also quantified by cell counting (see results on Supplementary Fig. 3a; for details, see Supplemental methods). For OMP staining, total area of OMP labelling was quantified and expressed in relative values of total olfactory epithelium area. This OMP area is correlated with the number of OMP-positive cells (r2 = 0.91, p < 0.05, data not shown). All statistical analysis were Mann-Whitney’s tests performed with Statistica software. All images were taken and all analyses were performed blindly of the experimental groups.
EOG recordings were performed from the olfactory mucosa in an opened nasal cavity on mouse hemi-heads as described earlier20. Mice hemi-heads were stimulated with the same odorants used for behavioral experiments: octanol and acetophenone. EOG voltage signals were analyzed using Clampfit 9.2 (Axon Instruments) to measure responses’ peak amplitude, area under curve, rise time, fast and slow decay times. Rise time and two decay times were normalized to the corresponding response peak amplitude prior to statistical analysis. For responses to various concentrations of odorants, two way ANOVAs followed by Fisher’s LSD post hoc tests were performed. For kinetics, Student’s t tests were performed. All statistical analyses were performed with Statistica software.
Patch-clamp recordings were performed as described earlier19,23,51. Olfactory epithelia were harvested from MOR23-IRES-tauEGFP mice and perfused with Ringer’s solution, which contained (in mM): NaCl 124, KCl 3, MgSO4 1.3, CaCl2 2, NaHCO3 26, NaH2PO4 1.25, glucose 15; pH 7.6 and 305 mOsm. Perforated patch-clamp was performed by including 260 μM nystatin in the recording pipette, which was filled with the following solution (in mM): KCl 70, KOH 53, methanesulfonic acid 30, EGTA 5, HEPES 10, sucrose 70; pH 7.2 (KOH) and 310 mOsm. OSNs were stimulated with pressure-delivered odorants52. Lyral was prepared in 0.5 M solution in dimethyl sulfoxide (DMSO) and kept at −20 °C. Forskolin was prepared in 10 mM stock solution in DMSO; IBMX was prepared in 100 mM stock solution in DMSO. Final solutions of odorants IBMX/forskolin were prepared before each experiment by adding Ringer. All chemicals were obtained from Sigma-Aldrich. Lyral was provided as a generous gift from International Fragrances and Flavors (Dijon, France). Analysis was performed using Fitmaster, SpAcAn add-on for Igor Pro53 and Origin. Statistical analysis (Student’s t tests, F-test) was performed using Origin software (OriginLabs).
The olfactory habituation/dishabituation test54, is used to test whether the animal can differentiate different odors. Here we modified a protocol from Yang and Crawley24 using a special apparatus (adapted from55) composed of a test area of 40 × 40 × 10 cm (length × width × height), with a hole in its center. Odorant was placed under litter in the hole. Animals were submitted to 6 consecutive trials of 3 minutes: 100 μl of mineral oil; 4 trials habituation (100 μl odorant 1: octanol) and dishabituation trial (100 μl odorant 2: acetophenone). Animals were filmed during the test (conducted in red lights). Movies were analyzed offline using a custom Matlab routine, which measures the number of visits and the length of each visit in the odorized hole: the mouse position was tracked to score these parameters. This process is completely automated; however a manual scoring was performed to exclude visits where the back of the animal (and not its head) is above the odorized hole. Mean visit durations were used for analysis.
Open field test
Mice were placed in the same apparatus without hole. Videos were processed using a custom Matlab routine that tracked mouse centroid positions during 5 min. Open field test scoring was completely automated. Total walking distance, average speed and thigmotaxis (expressed as the percentage of total time spent close to the walls) were measured.
Buried food test
We modified a protocol from Yang and Crowley24 in which we chose Leerdammer® cheese as the food stimulus instead of a chocolate. Food access was removed 5 hours before the experiment. Animals were placed in a conventional mouse cage (33 × 19 × 13 cm) filled with 6 cm of bedding. Food or control item was buried at one randomly chosen spot (out of 8) in the cage. Test ended once either the animals hold the item or did not achieve to find it within 10 minutes. Ability of animals to retrieve a visible food item on the bedding was tested in a conventional rat style cage (42 × 26 × 19 cm). The criterion to stop the experiment was when the animal started to eat the cheese.
During data analysis of all behavioral assays, experimenters were blind to the experimental groups.
All statistical analyses (using Statistica software) consisted in two way ANOVA followed by Fischer’s LSD post hoc tests except for the visible cheese experiment which was analyzed using a Student’s t test.
How to cite this article: Rivière, S. et al. High Fructose Diet inducing diabetes rapidly impacts olfactory epithelium and behavior in mice. Sci. Rep. 6, 34011; doi: 10.1038/srep34011 (2016).
Caillol, M., Aioun, J., Baly, C., Persuy, M. A. & Salesse, R. Localization of orexins and their receptors in the rat olfactory system: possible modulation of olfactory perception by a neuropeptide synthetized centrally or locally. Brain Res 960, 48–61 (2003).
Lacroix, M. C. et al. Expression of insulin system in the olfactory epithelium: first approaches to its role and regulation. J Neuroendocrinol 20, 1176–1190, 10.1111/j.1365-2826.2008.01777.x (2008).
Marks, D. R., Tucker, K., Cavallin, M. A., Mast, T. G. & Fadool, D. A. Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety and olfactory behaviors. J Neurosci 29, 6734–6751, 10.1523/JNEUROSCI.1350-09.2009 (2009).
Baly, C. et al. Leptin and its receptors are present in the rat olfactory mucosa and modulated by the nutritional status. Brain Res 1129, 130–141, 10.1016/j.brainres.2006.10.030 (2007).
Getchell, T. V., Kwong, K., Saunders, C. P., Stromberg, A. J. & Getchell, M. L. Leptin regulates olfactory-mediated behavior in ob/ob mice. Physiol Behav 87, 848–856, 10.1016/j.physbeh.2005.11.016 (2006).
Palouzier-Paulignan, B. et al. Olfaction under metabolic influences. Chemical senses 37, 769–797, 10.1093/chemse/bjs059 (2012).
Jia, C. & Hegg, C. C. Neuropeptide Y and extracellular signal-regulated kinase mediate injury-induced neuroregeneration in mouse olfactory epithelium. Mol Cell Neurosci 49, 158–170, 10.1016/j.mcn.2011.11.004 (2012).
Savigner, A. et al. Modulation of Spontaneous and Odorant-Evoked Activity of Rat Olfactory Sensory Neurons by Two Anorectic Peptides, Insulin and Leptin. J Neurophysiol 101, 2898–2906, 10.1152/jn.91169.2008 (2009).
Aime, P. et al. A physiological increase of insulin in the olfactory bulb decreases detection of a learned aversive odor and abolishes food odor-induced sniffing behavior in rats. Plos One 7, e51227, 10.1371/journal.pone.0051227 (2012).
Thiebaud, N. et al. Hyperlipidemic Diet Causes Loss of Olfactory Sensory Neurons, Reduces Olfactory Discrimination and Disrupts Odor-Reversal Learning. Journal of Neuroscience 34, 6970–6984, 10.1523/jneurosci.3366-13.2014 (2014).
Chen, L., Magliano, D. J. & Zimmet, P. Z. The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives. Nat Rev Endocrinol 8, 228–236, 10.1038/nrendo.2011.183 (2012).
Kharroubi, A. T. & Darwish, H. M. Diabetes mellitus: The epidemic of the century. World J Diabetes 6, 850–867, 10.4239/wjd.v6.i6.850 (2015).
Brady, S. et al. Presence of neuropathic pain may explain poor performances on olfactory testing in diabetes mellitus patients. Chemical senses 38, 497–507, 10.1093/chemse/bjt013 (2013).
Gouveri, E. et al. Olfactory dysfunction in type 2 diabetes mellitus: an additional manifestation of microvascular disease? Angiology 65, 869–876, 10.1177/0003319714520956 (2014).
Naka, A., Riedl, M., Luger, A., Hummel, T. & Mueller, C. A. Clinical significance of smell and taste disorders in patients with diabetes mellitus. Eur Arch Otorhinolaryngol 267, 547–550, 10.1007/s00405-009-1123-4 (2010).
DiNicolantonio, J. J., O’Keefe, J. H. & Lucan, S. C. Added fructose: a principal driver of type 2 diabetes mellitus and its consequences. Mayo Clin Proc 90, 372–381, 10.1016/j.mayocp.2014.12.019 (2015).
Cohen, A. M., Teitelbaum, A. & Rosenman, E. Diabetes induced by a high fructose diet. Metabolism 26, 17–24 (1977).
Panchal, S. K. & Brown, L. Rodent models for metabolic syndrome research. J Biomed Biotechnol 2011, 351982, 10.1155/2011/351982 (2011).
Cadiou, H. et al. Postnatal odorant exposure induces peripheral olfactory plasticity at the cellular level. J Neurosci 34, 4857–4870, 10.1523/JNEUROSCI.0688-13.2014 (2014).
Negroni, J. et al. Neuropeptide Y Enhances Olfactory Mucosa Responses to Odorant in Hungry Rats. Plos One 7, 10.1371/journal.pone.0045266 (2012).
Schwob, J. E. Neural regeneration and the peripheral olfactory system. The Anatomical record 269, 33–49 (2002).
Iatropoulos, M. J. & Williams, G. M. Proliferation markers. Exp Toxicol Pathol 48, 175–181, 10.1016/S0940-2993(96)80039-X (1996).
Jarriault, D. & Grosmaitre, X. Perforated Patch-clamp Recording of Mouse Olfactory Sensory Neurons in Intact Neuroepithelium: Functional Analysis of Neurons Expressing an Identified Odorant Receptor. J Vis Exp, 10.3791/52652 (2015).
Yang, M. & Crawley, J. N. Simple behavioral assessment of mouse olfaction. Curr Protoc Neurosci Chapter 8, Unit 8 24, 10.1002/0471142301.ns0824s48 (2009).
Lee, A. C., He, J. & Ma, M. Olfactory marker protein is critical for functional maturation of olfactory sensory neurons and development of mother preference. J Neurosci 31, 2974–2982, 10.1523/JNEUROSCI.5067-10.2011 (2011).
Farbman, A. I. & Margolis, F. L. Olfactory marker protein during ontogeny: immunohistochemical localization. Dev Biol 74, 205–215 (1980).
Margolis, F. L. A brain protein unique to the olfactory bulb. Proc Natl Acad Sci USA 69, 1221–1224 (1972).
Cavaghan, M. K., Ehrmann, D. A. & Polonsky, K. S. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 106, 329–333, 10.1172/JCI10761 (2000).
Lacroix, M. C. et al. Insulin but not leptin protects olfactory mucosa from apoptosis. J Neuroendocrinol 23, 627–640, 10.1111/j.1365-2826.2011.02154.x (2011).
Bell, G. I. & Polonsky, K. S. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414, 788–791, 10.1038/414788a (2001).
Forbes, J. M. & Cooper, M. E. Mechanisms of diabetic complications. Physiol Rev 93, 137–188, 10.1152/physrev.00045.2011 (2013).
Russell, J. W., Sullivan, K. A., Windebank, A. J., Herrmann, D. N. & Feldman, E. L. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6, 347–363, 10.1006/nbdi.1999.0254 (1999).
Leinninger, G. M. et al. Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1. Neurobiol Dis 23, 11–22, 10.1016/j.nbd.2006.01.017 (2006).
Schmeichel, A. M., Schmelzer, J. D. & Low, P. A. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 52, 165–171 (2003).
Montani, G., Tonelli, S., Elsaesser, R., Paysan, J. & Tirindelli, R. Neuropeptide Y in the olfactory microvillar cells. Eur J Neurosci 24, 20–24, 10.1111/j.1460-9568.2006.04878.x (2006).
Patel, J., Iyer, A. & Brown, L. Evaluation of the chronic complications of diabetes in a high fructose diet in rats. Indian J Biochem Biophys 46, 66–72 (2009).
Kaneko-Goto, T. et al. Goofy coordinates the acuity of olfactory signaling. J Neurosci 33, 12987–12996, 12996a, 10.1523/JNEUROSCI.4948-12.2013 (2013).
Kim, B. & Feldman, E. L. Insulin resistance in the nervous system. Trends Endocrinol Metab 23, 133–141, 10.1016/j.tem.2011.12.004 (2012).
Khanh, D. V., Choi, Y. H., Moh, S. H., Kinyua, A. W. & Kim, K. W. Leptin and insulin signaling in dopaminergic neurons: relationship between energy balance and reward system. Front Psychol 5, 846, 10.3389/fpsyg.2014.00846 (2014).
Cheng, Z., Tseng, Y. & White, M. F. Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab 21, 589–598, 10.1016/j.tem.2010.06.005 (2010).
Verkhratsky, A. & Fernyhough, P. Mitochondrial malfunction and Ca2+ dyshomeostasis drive neuronal pathology in diabetes. Cell Calcium 44, 112–122, 10.1016/j.ceca.2007.11.010 (2008).
Fluegge, D. et al. Mitochondrial Ca(2+) mobilization is a key element in olfactory signaling. Nat Neurosci 15, 754–762, 10.1038/nn.3074 (2012).
Zemdegs, J. et al. High fat diet-induced metabolic disorders impairs serotonergic function and anxiety-like behaviours in mice. Br J Pharmacol, 10.1111/bph.13343 (2015).
Tucker, K. et al. The Olfactory Bulb: A Metabolic Sensor of Brain Insulin and Glucose Concentrations via a Voltage-Gated Potassium Channel. Results Probl Cell Differ 52, 147–157, 10.1007/978-3-642-14426-4_12 (2010).
Al Koborssy, D. et al. Cellular and molecular cues of glucose sensing in the rat olfactory bulb. Front Neurosci 8, 333, 10.3389/fnins.2014.00333 (2014).
Fadool, D. A., Tucker, K. & Pedarzani, P. Mitral cells of the olfactory bulb perform metabolic sensing and are disrupted by obesity at the level of the Kv1.3 ion channel. Plos One 6, e24921, 10.1371/journal.pone.0024921 (2011).
Chess, D. J. et al. The antioxidant tempol attenuates pressure overload-induced cardiac hypertrophy and contractile dysfunction in mice fed a high-fructose diet. Am J Physiol Heart Circ Physiol 295, H2223–H2230, 10.1152/ajpheart.00563.2008 (2008).
Mellor, K. et al. High-fructose diet elevates myocardial superoxide generation in mice in the absence of cardiac hypertrophy. Nutrition 26, 842–848, 10.1016/j.nut.2009.08.017 (2010).
Laziz, I. et al. Endothelin as a neuroprotective factor in the olfactory epithelium. Neuroscience 172, 20–29, 10.1016/j.neuroscience.2010.10.063 (2011).
Francois, A. et al. Early survival factor deprivation in the olfactory epithelium enhances activity-driven survival. Front Cell Neurosci 7, 271, 10.3389/fncel.2013.00271 (2013).
Grosmaitre, X., Vassalli, A., Mombaerts, P., Shepherd, G. M. & Ma, M. Odorant responses of olfactory sensory neurons expressing the odorant receptor MOR23: a patch clamp analysis in gene-targeted mice. Proc Natl Acad Sci USA 103, 1970–1975, 10.1073/pnas.0508491103 (2006).
Grosmaitre, X., Santarelli, L. C., Tan, J., Luo, M. & Ma, M. Dual functions of mammalian olfactory sensory neurons as odor detectors and mechanical sensors. Nat Neurosci 10, 348–354, 10.1038/nn1856 (2007).
Dugue, G. P., Dumoulin, A., Triller, A. & Dieudonne, S. Target-dependent use of co-released inhibitory transmitters at central synapses. J Neurosci 25, 6490–6498, 10.1523/JNEUROSCI.1500-05.2005 (2005).
Gregg, B. & Thiessen, D. D. A simple method of olfactory discrimination of urines for the Mongolian gerbil, Meriones unguiculatus. Physiol Behav 26, 1133–1136 (1981).
Mandairon, N. et al. A computer-assisted odorized hole-board for testing olfactory perception in mice. J Neurosci Methods 180, 296–303, 10.1016/j.jneumeth.2009.04.008 (2009).
Authors would like to thank Anne Lefranc and the CSGA animal facility for excellent animal care, Dr. Xavier Fioramonti for advice on setting up the ipGTT experiments. Funding was provided to XG by CNRS through an ATIP and ATIP Plus grant, by the Regional Council of Burgundy France (FABER and PARI Agrale 1) and by the FEDER (European Funding for Regional Economical Development); SR received a doctoral fellowship from INRA ‘Alimentation Humaine’ Department and Conseil Régional de Bourgogne.
The authors declare no competing financial interests.
Electronic supplementary material
About this article
Cite this article
Rivière, S., Soubeyre, V., Jarriault, D. et al. High Fructose Diet inducing diabetes rapidly impacts olfactory epithelium and behavior in mice. Sci Rep 6, 34011 (2016). https://doi.org/10.1038/srep34011
Regulation of Metabolic Health by an “Olfactory-Hypothalamic Axis” and Its Possible Implications for the Development of Therapeutic Approaches for Obesity and T2D
Cellular and Molecular Neurobiology (2021)
Perinatal exposure to diets with different n-6:n-3 fatty acid ratios affects olfactory tissue fatty acid composition
Scientific Reports (2020)
Neurochemical Research (2020)
Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin
Acta Neuropathologica Communications (2018)